Total planned funding: $858,731,097
Clear active filters
Not Available
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Tanzania | $118,766,351 |
Kenya | $115,305,356 |
South Africa | $96,718,159 |
Uganda | $93,868,954 |
Nigeria | $84,298,946 |
Zambia | $68,575,373 |
Côte d'Ivoire | $41,066,503 |
Ethiopia | $39,845,408 |
Haiti | $27,222,867 |
Cameroon | $18,382,258 |
Zimbabwe | $16,945,254 |
Ukraine | $14,999,720 |
Central America Region | $13,807,226 |
Mozambique | $13,271,028 |
Eswatini | $12,181,521 |
Burundi | $12,131,842 |
Lesotho | $11,822,398 |
Namibia | $10,198,410 |
Cambodia | $8,043,049 |
Democratic Republic of the Congo | $7,900,583 |
Vietnam | $7,732,486 |
India | $5,850,000 |
Malawi | $4,702,800 |
Ghana | $4,375,000 |
Central Asia Region | $3,800,000 |
Botswana | $1,918,284 |
Papua New Guinea | $1,204,590 |
Rwanda | $1,037,553 |
South Sudan | $929,565 |
Indonesia | $500,000 |
Angola | $375,000 |
Caribbean Region | $361,456 |
Asia Regional Program | $308,157 |
Dominican Republic | $285,000 |
Burma | $0 |
Program Areas
Treatment | $229,529,000 |
Care | $221,947,812 |
Prevention | $204,008,935 |
Governance and Systems | $121,109,005 |
Testing | $90,375,683 |
Budget Codes
HTXS: Treatment: Adult Treatment | $196,097,508 |
HKID: Care: Orphans and Vulnerable Children | $129,987,168 |
HVCT: Testing: HIV Testing and Counseling | $90,375,683 |
HVOP: Sexual Prevention: Other Sexual Prevention | $88,663,500 |
HBHC: Care: Adult Care and Support | $57,974,762 |
HVSI: Strategic Information | $53,631,872 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $48,116,728 |
OHSS: Health Systems Strengthening | $48,033,576 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $42,655,662 |
PDTX: Treatment: Pediatric Treatment | $20,920,532 |
HVTB: Care: TB/HIV | $19,585,521 |
HLAB: Laboratory Infrastructure | $19,443,557 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $16,466,377 |
PDCS: Care: Pediatric Care and Support | $14,400,361 |
HTXD: Treatment: ARV Drugs | $12,510,960 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $6,468,785 |
HMBL: Biomedical Prevention: Blood Safety | $1,581,062 |
HMIN: Biomedical Prevention: Injection Safety | $56,821 |